✦ LIBER ✦

Two Doses of Oxaliplatin with Capecitabine (XELOX) in Metastatic Colorectal Cancer

✍ Scribed by Isabel Moreno-Solórzano; Rafael Ibeas-Rollan; Mariano Monzó-Planella; José Moreno-Solórzano; Francisco Martínez-Ródenas; Edmon Pou-Sanchis; Raquel Hernández-Borlan; Marta Navarro-Vigo; Silvia Ortigosa-Rodríguez; Bernat Gel-Moreno

Book ID: 119935105
Publisher: CIG Media Group, LP.
Year: 2007
Tongue: English
Weight: 116 KB
Volume: 6
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2007.n.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine plus oxaliplatin (xelox) in

Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer

✍ Emel Yaman; Aytug Uner; Ozlem Er; Ugur Coskun; Suleyman Buyukberber; Mustafa Dik 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 140 KB

Phase I pharmacokinetic study of chronom

Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer

✍ Farid, Mohamad; Chowbay, Balram; Chen, Xiangai; Tan, Sze Huey; Ramasamy, Saminat 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 330 KB

Biweekly XELOX (capecitabine and oxalipl

Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer

✍ Grande, Carlos; Quintero, Guillermo; Candamio, Sonia; París Bouzas, Lorena; Vill 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 337 KB

Capecitabine + oxaliplatin vs fluorourac

Capecitabine + oxaliplatin vs fluorouracil + folinic acid + oxaliplatin in metastatic colorectal cancer

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

A Phase II Study of Capecitabine Plus Ox

A Phase II Study of Capecitabine Plus Oxaliplatin (XELOX): A New First-Line Option in Metastatic Colorectal Cancer

✍ Makatsoris, Thomas ;Kalofonos, Haralabos P. ;Aravantinos, Gerasimos ;Papadimitri 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 93 KB

Capecitabine plus oxaliplatin (XELOX) ve

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer

✍ Michel Ducreux; Jaafar Bennouna; Mohamed Hebbar; Marc Ychou; Gérard Lledo; Thier 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 440 KB

## Abstract A regimen consisting of 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) is widely used in France in the first‐line treatment of metastatic colorectal cancer (MCRC). The aim of our study was to demonstrate the non‐inferiority of capecitabine plus oxaliplatin (XELOX) __versus__ FOLF